Immuno-Oncology Xchange | September 21, 2021 | Hybrid

Talk: Defining the key elements of IO translational research tissue endpoints in drug development

Presenters: Kenneth Bloom, M.D., Chief Medical Officer, Invicro

Joseph Krueger, Ph.D., Vice President of Research & Applications, Invicro

Learn More